Zong L, Zheng Y, Yu X, Dai X, Huang R, Yan G
Int J Med Sci. 2024; 21(10):1890-1902.
PMID: 39113896
PMC: 11302565.
DOI: 10.7150/ijms.95952.
Zhang W, Le L, Ahmad G, Molehin A, Siddiqui A, Torben W
Front Immunol. 2020; 11:1246.
PMID: 32636844
PMC: 7318103.
DOI: 10.3389/fimmu.2020.01246.
Lo D, Anderson D, Song M, Leopardi F, Farris A, Strobert E
Am J Transplant. 2015; 15(4):984-92.
PMID: 25703015
PMC: 4628789.
DOI: 10.1111/ajt.13100.
Abdoli R, Najafian N
Int J Organ Transplant Med. 2014; 5(3):97-110.
PMID: 25184030
PMC: 4149737.
Moyo N, Marchi E, Steinbach F
Immunology. 2013; 139(4):472-83.
PMID: 23461413
PMC: 3719064.
DOI: 10.1111/imm.12094.
The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells.
Magee C, Boenisch O, Najafian N
Am J Transplant. 2012; 12(10):2588-600.
PMID: 22759274
PMC: 3459149.
DOI: 10.1111/j.1600-6143.2012.04180.x.
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.
Marafioti T, Paterson J, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M
Haematologica. 2010; 95(3):432-9.
PMID: 20207847
PMC: 2833073.
DOI: 10.3324/haematol.2009.010991.
The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells.
Bauquet A, Jin H, Paterson A, Mitsdoerffer M, Ho I, Sharpe A
Nat Immunol. 2008; 10(2):167-75.
PMID: 19098919
PMC: 2742982.
DOI: 10.1038/ni.1690.
Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.
Xing L, Yang P, Wu C, Jin H, Chen X, Gao Y
Graefes Arch Clin Exp Ophthalmol. 2006; 244(12):1650-8.
PMID: 16601981
DOI: 10.1007/s00417-005-0207-0.
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).
Blazar B, Murphy W
Philos Trans R Soc Lond B Biol Sci. 2005; 360(1461):1747-67.
PMID: 16147539
PMC: 1569546.
DOI: 10.1098/rstb.2005.1701.
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
Harada H, Salama A, Sho M, Izawa A, Sandner S, Ito T
J Clin Invest. 2003; 112(2):234-43.
PMID: 12865411
PMC: 164288.
DOI: 10.1172/JCI17008.
Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis.
Rutitzky L, Ozkaynak E, Rottman J, Stadecker M
Infect Immun. 2003; 71(7):4040-4.
PMID: 12819093
PMC: 161982.
DOI: 10.1128/IAI.71.7.4040-4044.2003.
Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.
Lohning M, Hutloff A, Kallinich T, Mages H, Bonhagen K, Radbruch A
J Exp Med. 2003; 197(2):181-93.
PMID: 12538658
PMC: 2193816.
DOI: 10.1084/jem.20020632.
ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
Khayyamian S, Hutloff A, Buchner K, Grafe M, Henn V, Kroczek R
Proc Natl Acad Sci U S A. 2002; 99(9):6198-203.
PMID: 11983910
PMC: 122926.
DOI: 10.1073/pnas.092576699.
